The Effect of Coleus Forskohlii Extract on the Risk Factors of Metabolic Syndrome

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE3

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-04-30

Study Completion Date

2015-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Coleus forskohlii extract contains the bioactive compound, forskolin. Preliminary studies have shown that forskolin can increase fat metabolism thus reduce fat accumulation in both animals and humans. It has been suggested that forskolin may also suppress appetite thus reduce energy intake and results in weight loss. This study will evaluate the appetite suppressant properties of Coleus forskohlii extract. In addition the effect on central obesity and risk factors of metabolic syndrome will also be investigated.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Anti-obesity Effects of Dandelion (Taraxacum Officinale L.)

NCT06625736

Obese Women Perimenopause

COMPLETED NA

Efficacy and Safety of Platycodon Grandiflorus Extract(GCWB107) on Decrease of Body Fat

NCT04023864

Body Fat

UNKNOWN NA

Efficacy and Safety of Unripe Bokbunja Extract on Improvement of Blood Cholesterol

NCT03649620

Blood Cholesterol

COMPLETED NA

The Effect of Olive Leaf Extract Administration on Cardiovascular Health

NCT02990637

Overweight and Obesity Elevated Cholesterol

COMPLETED NA

Effect of Aged Garlic Extract on Atherosclerosis

NCT01534910

Metabolic Syndrome

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Metabolic Syndrome Obesity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Coleus forskohlii extract

Ingestion of 250 mg capsle (Coleus forskohlii extract) twice a day for 12 weeks

Group Type EXPERIMENTAL

Coleus forskohlii extract

Intervention Type DIETARY_SUPPLEMENT

Ingestion of 250 mg Coleus forskohlii extract capsule twice a day for 12 weeks

Placebo

Ingestion of 250 mg capsule (placebo) twice a day for 12 weeks

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type OTHER

Ingestion of 250 mg placebo capsule twice a day for 12 weeks

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Coleus forskohlii extract

Ingestion of 250 mg Coleus forskohlii extract capsule twice a day for 12 weeks

Intervention Type DIETARY_SUPPLEMENT

Placebo

Ingestion of 250 mg placebo capsule twice a day for 12 weeks

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Both Australian males and females, age 20-60 years, Overweight or obese (BMI \>25), waist circumference of \> 94 cm (male), waist circumference of \>80 cm (female)